Cereius

About:

Cereius is a pre-clinical stage company developing novel approaches to treat solid tumour brain metastasis.

Website: https://cereius.io

Twitter/X: cereius

Top Investors: North Carolina Biotechnology Center, BioInnovation

Description:

Cereius is a pre-clinical stage company developing novel approaches to treating solid tumor brain metastasis. Cereius’ novel radiolabeling chemistries increase the uptake and retention of radionuclides in the target tumor while minimizing uptake by normal tissues, significantly enhancing the therapeutic index and diagnostic contrast of targeting agents.

Total Funding Amount:

$7.25M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2017-01-01

Contact Email:

Info(AT)Cereius.io

Founders:

Kimberly Blackwell, Michael R. Zalutsky

Number of Employees:

1-10

Last Funding Date:

2020-05-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai